Elevance Health, INC (F.K.A. Anthem, INC. & Wellpoint, INC.)

Based in IN

🤖

AI Overview

With $2.8M in lobbying spend across 34 quarterly filings, Elevance Health, INC (F.K.A. Anthem, INC. & Wellpoint, INC.) is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$2.8M
Total Spend
8
Years Active
1
Firms Hired
12
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$360K
2019$360K
2020$360K
2021$450K
2022$450K
2023$300K
2024$280K
2025$260K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Taxation, Health Issues, Medicare/Medicaid, Veterans

  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations
  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments,
  • PL 111-148 - The Patient Protection and Affordable Care Act, implementation
  • H.R. 1628 - American Health Care Act of 2017
  • H.R. 246 - health insurance tax repeal
  • H.R. 1101 - Small Business Health Care F
  • PL 111-148 - The Patient Protection and Affordable Care Act, implementation
  • S. 870 - Chronic Care
  • H.R. 3168 - Special Needs Plans Reauthorization
  • H.R. 3178 - Medicare Part B Improvement Act
  • H.R. 3921
  • budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations
  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • 2019 Appropriations

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.